Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Registration fees
Hotel
Venue
Helpful info
Travel info
Programme
Abstract Submission
Postgraduate Teaching
Nurse Programme
Hands-on
Information for Presenters
In-person Networking
myUEG Community Area
Learn from Leaders
Mentoring
The UEG Night
Let's Meet
Women in GI Networking
Industry Programme
Industry Exhibition
Industry Symposia
Meet the experts sessions
Innovation Hub
List of Supporters & Exhibitors
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Shomron Ben-Horin
Getting the best out of anti-TNF therapy
Shomron Ben-Horin
Lower GI symptoms in infectious disease: Introduction
Shomron Ben-Horin
Can we rely on clinical assessment for long-term monitoring? Yes and no
Shomron Ben-Horin
et al.
The New Treatment Platform of Subcutaneous TNF Inhibitors in Inflammatory Bowel Disease (Celltrion Healthcare)
Shomron Ben-Horin
et al.
The refractory proctitis patient: Diagnostic pitfalls and innovative therapies
Shomron Ben-Horin
Precision medicine with precision tools in Crohn’s disease: can we translate science into clinical practice? (Takeda)
Shomron Ben-Horin
et al.
COMPARISON OF COMBINATION SUBCUTANEOUS INFLIXIMAB AND AN IMMUNOMODULATOR VERSUS SUBCUTANEOUS INFLIXIMAB MONOTHERAPY: POST-HOC ANALYSIS OF A RANDOMISED CLINICAL TRIAL
PERSONALIZED ELIMINATION DIET GUIDED BY LEUKOCYTES ACTIVATION TO FOOD FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND RANDOMIZED SHAM-CONTROLLED STUDY
Shomron Ben-Horin
et al.
ARTIFICIAL INTELLIGENCE- AIDED COLONOSCOPY DOES NOT INCREASE ADENOMA DETECTION RATE IN ROUTINE CLINICAL PRACTICE
Shomron Ben-Horin
et al.
AUTOMATED GRADING OF ULCER SEVERITY ON VIDEO-CAPSULE IMAGES OF CROHN'S DISEASE WITH CONVOLUTIONAL NEURAL NETWORKS
Shomron Ben-Horin
et al.
POST-OPERATIVE OUTCOMES FOLLOWING INGUINAL HERNIA REPAIR IN IBD PATIENTS COMPARED TO MATCHED CONTROLS - A CASE CONTROL STUDY
Shomron Ben-Horin
et al.
COMPARISON OF COMBINATION SUBCUTANEOUS INFLIXIMAB AND AN IMMUNOMODULATOR VERSUS SUBCUTANEOUS INFLIXIMAB MONOTHERAPY: POST-HOC ANALYSIS OF A RANDOMISED CLINICAL TRIAL
Shomron Ben-Horin
et al.
REAL-WORLD EXPOSURE-RESPONSE RELATIONSHIP OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A POOLED MULTICENTRE OBSERVATIONAL COHORT ANALYSIS OF CLINICAL AND MODELED PHARMACOLOGICAL DATA
Shomron Ben-Horin
et al.
SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH ACTIVE INFLAMMATORY BOWEL DISEASE: POST-HOC ANALYSIS OF PRE/POST SWITCH OUTCOMES FROM A MULTICENTRE, RANDOMISED CONTROLLED PIVOTAL TRIAL
Shomron Ben-Horin
et al.
EVALUATION OF CLINICAL RELATIONSHIP BETWEEN FECAL CALPROTECTIN AND ENDOSCOPIC FINDINGS IN ULCERATIVE COLITIS PATIENTS TREATED WITH INFLIXIMAB (CT-P13) SUBCUTANEOUS AND INTRAVENOUS THERAPY: RESULTS FROM A MULTICENTER, RANDOMIZED, CONTROLLED PIVOTAL TRIAL
Shomron Ben-Horin
et al.
QINGDAI (QD) FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RETROSPECTIVE ISRAELI NATIONAL EXPERIENCE
Shomron Ben-Horin
et al.
EXPOSURE-RESPONSE RELATIONSHIP OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) IN PATIENTS WITH ACTIVE CROHN'S DISEASE AND ULCERATIVE COLITIS: ANALYSIS FROM A MULTICENTER, RANDOMIZED CONTROLLED PIVOTAL TRIAL
Shomron Ben-Horin
et al.
UNTARGETED SERUM METABOLOME IN LONGITUDINAL CROHN'S DISEASE (CD) COHORT ENROLLED DURING REMISSION SHOWS STRONG INDIVIDUALIZED SIGNATURE AND CD-ASSOCIATED SIGNALS THAT ARE MAINTAINED ALSO IN PATIENTS WHO NORMALIZED THEIR FECAL CALPROTECTIN
Shomron Ben-Horin
et al.
SEROLOGIC RESPONSE AND SAFETY AFTER THIRD DOSE OF THE COVID-19 BNT162B2 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
Shomron Ben-Horin
et al.
Item 1 - 19 / 19
1
Chat with us
, powered by
LiveChat